Avion Wealth’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19K Buy
216
+59
+38% +$4.94K ﹤0.01% 402
2026
Q1
$12K Buy
157
+28
+22% +$2.31K ﹤0.01% 438
2025
Q4
$10K Buy
129
+6
+5% +$492 ﹤0.01% 483
2025
Q3
$9K Sell
123
-22
-15% -$1.72K ﹤0.01% 500
2025
Q2
$11K Buy
145
+91
+169% +$6.79K ﹤0.01% 440
2025
Q1
$3K Hold
54
﹤0.01% 631
2024
Q4
$3K Buy
54
+18
+50% +$1.26K ﹤0.01% 629
2024
Q3
$2K Sell
36
-17
-32% -$1.24K ﹤0.01% 672
2024
Q2
$4K Sell
53
-3
-5% -$266 ﹤0.01% 502
2024
Q1
$6K Buy
56
+11
+24% +$924 ﹤0.01% 416
2023
Q4
$3K Sell
45
-6
-12% -$417 ﹤0.01% 482
2023
Q3
$3K Sell
51
-7
-12% -$563 ﹤0.01% 417
2023
Q2
$4K Buy
58
+37
+176% +$3.22K ﹤0.01% 374
2023
Q1
$1K Hold
21
﹤0.01% 437
2022
Q4
$1K Hold
21
﹤0.01% 418
2022
Q3
$2K Sell
21
-18
-46% -$1.73K ﹤0.01% 393
2022
Q2
$4K Buy
+39
New +$4.04K ﹤0.01% 342

Other funds holding EW

Avion Wealth's EW Position: Q2 2026 in Review

Avion Wealth increased its Edwards Lifesciences (EW) stake by 38% in Q2 2026, buying an estimated $4.94K and bringing the position to 216 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #402.

Avion Wealth first reported a position in EW in Q2 2022 and has held it in 17 quarters since. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Avion Wealth held 216 shares of Edwards Lifesciences worth $19K as of Q2 2026.
  • Avion Wealth bought 59 Edwards Lifesciences shares in Q2 2026, an estimated $4.94K.
  • Edwards Lifesciences made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #402 holding.
  • Avion Wealth first reported a position in Edwards Lifesciences in Q2 2022 and has held it in 17 quarters since.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.